The Cooper Companies, Inc.

NasdaqGS:COO Stock Report

Market Cap: US$19.8b

Cooper Companies Valuation

Is COO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of COO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: COO ($99.48) is trading below our estimate of fair value ($168.7)

Significantly Below Fair Value: COO is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for COO?

Key metric: As COO is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for COO. This is calculated by dividing COO's market cap by their current earnings.
What is COO's PE Ratio?
PE Ratio55.2x
EarningsUS$359.30m
Market CapUS$19.84b

Price to Earnings Ratio vs Peers

How does COO's PE Ratio compare to its peers?

The above table shows the PE ratio for COO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average35.3x
ALGN Align Technology
38.9x17.5%US$16.7b
SOLV Solventum
16.1x6.0%US$11.7b
MMSI Merit Medical Systems
50.5x14.2%US$5.9b
HAE Haemonetics
35.8x24.7%US$4.5b
COO Cooper Companies
55.1x23.0%US$19.8b

Price-To-Earnings vs Peers: COO is expensive based on its Price-To-Earnings Ratio (55.1x) compared to the peer average (35.3x).

Price to Earnings Ratio vs Industry

How does COO's PE Ratio compare vs other companies in the US Medical Equipment Industry?

4 CompaniesPrice / EarningsEstimated GrowthMarket Cap
MHUA Meihua International Medical Technologies
1.5xn/aUS$12.37m
PAVM PAVmed
0.7x-77.8%US$11.86m
RTSL Rapid Therapeutic Science Laboratories
0.3xn/aUS$18.99k
UTRS Minerva Surgical
n/an/aUS$8.00
No more companies available in this PE range
COO 55.2xIndustry Avg. 37.2xNo. of Companies11PE020406080100+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: COO is expensive based on its Price-To-Earnings Ratio (55.1x) compared to the US Medical Equipment industry average (37.2x).

Price to Earnings Ratio vs Fair Ratio

What is COO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

COO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio55.2x
Fair PE Ratio38.1x

Price-To-Earnings vs Fair Ratio: COO is expensive based on its Price-To-Earnings Ratio (55.1x) compared to the estimated Fair Price-To-Earnings Ratio (38.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst COO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$99.48
US$114.29
+14.9%
9.2%US$130.00US$92.12n/a14
Nov ’25US$105.85
US$114.29
+8.0%
9.2%US$130.00US$92.12n/a14
Oct ’25US$108.36
US$113.51
+4.8%
8.9%US$130.00US$92.12n/a14
Sep ’25US$105.73
US$114.08
+7.9%
8.0%US$125.00US$95.00n/a13
Aug ’25US$94.20
US$111.46
+18.3%
7.9%US$125.00US$95.00n/a13
Jul ’25US$86.39
US$109.72
+27.0%
8.6%US$125.00US$95.00n/a14
Jun ’25US$94.31
US$108.16
+14.7%
10.0%US$125.00US$86.25n/a15
May ’25US$89.66
US$107.90
+20.3%
9.6%US$125.00US$86.25n/a16
Apr ’25US$99.24
US$107.40
+8.2%
9.5%US$125.00US$86.25n/a16
Mar ’25US$102.19
US$102.81
+0.6%
9.7%US$116.00US$84.30n/a16
Feb ’25US$95.38
US$97.85
+2.6%
8.2%US$110.00US$84.25n/a16
Jan ’25US$94.61
US$96.57
+2.1%
8.2%US$107.50US$84.25n/a16
Dec ’24US$85.27
US$98.10
+15.0%
7.6%US$107.50US$85.75n/a15
Nov ’24US$79.23
US$98.25
+24.0%
7.6%US$107.50US$85.75US$105.8515
Oct ’24US$79.50
US$100.57
+26.5%
7.6%US$110.00US$86.25US$108.3614
Sep ’24US$91.17
US$101.16
+11.0%
7.3%US$110.00US$86.25US$105.7314
Aug ’24US$97.50
US$100.38
+2.9%
8.3%US$110.00US$81.25US$94.2014
Jul ’24US$95.86
US$99.50
+3.8%
7.8%US$107.75US$81.25US$86.3914
Jun ’24US$93.55
US$97.43
+4.2%
9.2%US$107.50US$80.00US$94.3113
May ’24US$95.94
US$93.46
-2.6%
8.0%US$107.50US$80.00US$89.6612
Apr ’24US$93.34
US$88.65
-5.0%
8.5%US$97.50US$70.00US$99.2412
Mar ’24US$80.89
US$86.90
+7.4%
9.6%US$96.25US$70.00US$102.1912
Feb ’24US$89.15
US$86.90
-2.5%
9.6%US$96.25US$70.00US$95.3812
Jan ’24US$82.67
US$85.21
+3.1%
8.4%US$93.75US$70.00US$94.6112
Dec ’23US$81.66
US$84.43
+3.4%
8.5%US$92.50US$70.00US$85.2710
Nov ’23US$69.75
US$83.55
+19.8%
9.2%US$93.75US$70.00US$79.2310

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Elevance Health

US$92.9b

Operates as a health benefits company in the United States.

ELV

US$400.70

7D

-5.8%

1Y

-13.9%

CVS Health

US$66.9b

Provides health solutions in the United States.

CVS

US$56.05

7D

0.4%

1Y

-17.9%

Patterson Companies

US$1.7b

Engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada.

PDCO

US$20.90

7D

-0.7%

1Y

-34.7%